Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard F Ecker

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 22, 2014
A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinitiesJohanna Michl, Christian Scharinger, Miriam Zauner, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
A subset of highly effective propafenone-type multidrug resistance modulators lacks effects on cardiac action potential and mechanical twitch parameters of rat papillary musclesDiethart Schmid, Dawid L Staudacher, Hans G Loew, et al.
Scientific Reports|October 8, 2020
ATP modulates SLC7A5 (LAT1) synergistically with cholesterolJessica Cosco, Mariafrancesca Scalise, Claire Colas, et al.
Frontiers in Pharmacology|April 26, 2021
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity <i>in vitro</i>Marco Niello, Daniela Cintulová, Philip Raithmayr, et al.
Journal of Chemical Information and Modeling|December 1, 2018
Predicting Residence Time and Drug Unbinding Pathway through Scaled Molecular DynamicsDoris A Schuetz, Mattia Bernetti, Martina Bertazzo, et al.
Nature Chemical Biology|March 27, 2012
Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligandsLars Richter, Chris de Graaf, Werner Sieghart, et al.
The Journal of Biological Chemistry|May 12, 2011
Random mutagenesis of the prokaryotic peptide transporter YdgR identifies potential periplasmic gating residuesElisabeth Malle, Hongwen Zhou, Jana Neuhold, et al.
Molecular Pharmacology|August 12, 2004
A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrAGerhard F Ecker, Karin Pleban, Stephan Kopp, et al.
Chemmedchem|March 13, 2016
Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP)Theresa Schwarz, Floriane Montanari, Anna Cseke, et al.
Neurochemical Research|April 6, 2020
Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure EffectsMaria E K Lie, Stefanie Kickinger, Jonas Skovgaard-Petersen, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 22, 2014
A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinitiesJohanna Michl, Christian Scharinger, Miriam Zauner, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
A subset of highly effective propafenone-type multidrug resistance modulators lacks effects on cardiac action potential and mechanical twitch parameters of rat papillary musclesDiethart Schmid, Dawid L Staudacher, Hans G Loew, et al.
Scientific Reports|October 8, 2020
ATP modulates SLC7A5 (LAT1) synergistically with cholesterolJessica Cosco, Mariafrancesca Scalise, Claire Colas, et al.
Frontiers in Pharmacology|April 26, 2021
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity <i>in vitro</i>Marco Niello, Daniela Cintulová, Philip Raithmayr, et al.
Journal of Chemical Information and Modeling|December 1, 2018
Predicting Residence Time and Drug Unbinding Pathway through Scaled Molecular DynamicsDoris A Schuetz, Mattia Bernetti, Martina Bertazzo, et al.
Nature Chemical Biology|March 27, 2012
Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligandsLars Richter, Chris de Graaf, Werner Sieghart, et al.
The Journal of Biological Chemistry|May 12, 2011
Random mutagenesis of the prokaryotic peptide transporter YdgR identifies potential periplasmic gating residuesElisabeth Malle, Hongwen Zhou, Jana Neuhold, et al.
Molecular Pharmacology|August 12, 2004
A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrAGerhard F Ecker, Karin Pleban, Stephan Kopp, et al.
Chemmedchem|March 13, 2016
Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP)Theresa Schwarz, Floriane Montanari, Anna Cseke, et al.
Neurochemical Research|April 6, 2020
Pharmacological Characterization of a Betaine/GABA Transporter 1 (BGT1) Inhibitor Displaying an Unusual Biphasic Inhibition Profile and Anti-seizure EffectsMaria E K Lie, Stefanie Kickinger, Jonas Skovgaard-Petersen, et al.
Pageof 19